<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Eleven patients with mild <z:e sem="disease" ids="C0268306" disease_type="Disease or Syndrome" abbrv="">unconjugated hyperbilirubinaemia</z:e> (<z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>) took part in a double-blind cross-over trial of <z:chebi fb="0" ids="8069">phenobarbitone</z:chebi> and phetharbital, a non-hypnotic <z:chebi fb="8" ids="29745">barbiturate</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Significant reductions in plasma <z:chebi fb="0" ids="16990">bilirubin</z:chebi> were observed with both drugs, but six patients complained of sleepiness on <z:chebi fb="0" ids="8069">phenobarbitone</z:chebi>, and phetharbital was preferred by most patients </plain></SENT>
<SENT sid="2" pm="."><plain>Phetharbital was also effective in the rare severe <z:e sem="disease" ids="C0268306" disease_type="Disease or Syndrome" abbrv="">unconjugated hyperbilirubinaemia</z:e> of the <z:e sem="disease" ids="C0010324" disease_type="Disease or Syndrome" abbrv="">Crigler-Najjar syndrome</z:e> (Type 2) </plain></SENT>
<SENT sid="3" pm="."><plain>Symptoms attributed to <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>, including <z:hpo ids='HP_0002018'>nausea</z:hpo> and <z:hpo ids='HP_0002027'>abdominal pain</z:hpo>, were less consistently relieved </plain></SENT>
</text></document>